Conference - London, United Kingdom
The fifth joint UK BioIndustry Association (BIA) and Medicines and Healthcare Products Regulatory Agency (MHRA) conference provides the opportunity to showcase the collaborative approach between stakeholders to support innovation and to facilitate clinical development and timely access to new treatments and vaccines.
An informative keynote presentation on patient access to innovative therapies and technologies from Professor Sir Michael Rawlins, Chairman, MHRA, will kick-off the conference.
The conference will be the ideal place to hear the very latest thinking from senior experts and leading speakers from the MHRA and NIBSC, the life science industry, the Wellcome Trust, the Jenner Institute and patient organisations on topics including:
• Patient involvement in regulatory decision-making and drug development
• NIBSC MHRA post-merger: this session is focusing on advanced therapy medicinal products and biosimilars
• Accelerated regulatory approvals and processes – case study: Response against the Ebola Virus Disease from bench science to clinical research, lessons learnt and applicability to other therapeutic areas.
- Organization: BioIndustry Association (BIA)
Thu, Jun 11, 2015 - Thu, Jun 11, 2015
The Wellcome Trust
Gibbs Building, 215 Euston Road, London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.